These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 28269782

  • 1. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 2. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
    McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B, Robertson J, Tartaglia MC.
    Mol Neurobiol; 2018 Dec 10; 55(12):8826-8841. PubMed ID: 29603092
    [Abstract] [Full Text] [Related]

  • 4. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
    Kiko T, Nakagawa K, Tsuduki T, Furukawa K, Arai H, Miyazawa T.
    J Alzheimers Dis; 2014 Dec 10; 39(2):253-9. PubMed ID: 24157723
    [Abstract] [Full Text] [Related]

  • 5. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ.
    Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
    Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H.
    PLoS One; 2015 Sep 08; 10(5):e0126423. PubMed ID: 25992776
    [Abstract] [Full Text] [Related]

  • 7. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A, Molinuevo JL, Altirriba J, Sánchez-Valle R, Alcolea D, Fortea J, Rami L, Balasa M, Muñoz-García C, Ezquerra M, Fernández-Santiago R, Lleó A, Lladó A, Antonell A.
    Mol Neurobiol; 2017 Nov 08; 54(9):6647-6654. PubMed ID: 27738874
    [Abstract] [Full Text] [Related]

  • 8. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S, Reddy PH.
    Biochim Biophys Acta; 2016 Sep 08; 1862(9):1617-27. PubMed ID: 27264337
    [Abstract] [Full Text] [Related]

  • 9. Characterization of Alzheimer's Disease Micro-RNA Profile in Exosome-Enriched CSF Samples.
    Riancho J, Santurtun A, Sánchez-Juan P.
    Methods Mol Biol; 2019 Sep 08; 2044():343-352. PubMed ID: 31432424
    [Abstract] [Full Text] [Related]

  • 10. Exosomal microRNA profiles from serum and cerebrospinal fluid in neurosyphilis.
    Chen H, Zhou Y, Wang ZY, Yan BX, Zhou WF, Wang TT, Zheng M, Man XY.
    Sex Transm Infect; 2019 Jun 08; 95(4):246-250. PubMed ID: 30926713
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
    Müller M, Jäkel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM.
    Mol Neurobiol; 2016 Jul 08; 53(5):2894-2899. PubMed ID: 25895659
    [Abstract] [Full Text] [Related]

  • 12. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.
    Mol Neurobiol; 2017 Sep 08; 54(7):5550-5562. PubMed ID: 27631879
    [Abstract] [Full Text] [Related]

  • 13. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
    van Harten AC, Mulders J, Scheltens P, van der Flier WM, Oudejans CB.
    J Alzheimers Dis; 2015 Sep 08; 47(1):243-52. PubMed ID: 26402772
    [Abstract] [Full Text] [Related]

  • 14. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C, Hejl AM, Heegaard NHH, Carlsen AL, Burton M, Lilje B, Winge K.
    Mov Disord; 2019 Feb 08; 34(2):246-254. PubMed ID: 30557454
    [Abstract] [Full Text] [Related]

  • 15. The Serum Exosome Derived MicroRNA-135a, -193b, and -384 Were Potential Alzheimer's Disease Biomarkers.
    Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC.
    Biomed Environ Sci; 2018 Feb 08; 31(2):87-96. PubMed ID: 29606187
    [Abstract] [Full Text] [Related]

  • 16. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
    Dakterzada F, Targa A, Benítez ID, Romero-ElKhayat L, de Gonzalo-Calvo D, Torres G, Moncusí-Moix A, Huerto R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G.
    Alzheimers Res Ther; 2020 Dec 05; 12(1):163. PubMed ID: 33278902
    [Abstract] [Full Text] [Related]

  • 17. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
    Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.
    PLoS One; 2015 Dec 05; 10(10):e0139233. PubMed ID: 26426747
    [Abstract] [Full Text] [Related]

  • 18. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M, Kuiperij HB, Claassen JA, Küsters B, Verbeek MM.
    Neurobiol Aging; 2014 Jan 05; 35(1):152-8. PubMed ID: 23962497
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.
    Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, Rohrer JD, Tartaglia MC, Robertson J, Genetic FTD Initiative (GENFI).
    J Neurol Neurosurg Psychiatry; 2018 Aug 05; 89(8):851-858. PubMed ID: 29434051
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.